BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 29880387)

  • 1. Azithromycin Fails to Prevent Accelerated Airway Obliteration in T-bet
    Lendermon EA; Dodd-O JM; Coon TA; Wang X; Ensor CR; Cardenes N; Koodray CL; Heusey HL; Bennewitz MF; Sundd P; Bullock GC; Popescu I; Guo L; O'Donnell CP; Rojas M; McDyer JF
    Transplant Proc; 2018 Jun; 50(5):1566-1574. PubMed ID: 29880387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8(+)IL-17(+) T Cells Mediate Neutrophilic Airway Obliteration in T-bet-Deficient Mouse Lung Allograft Recipients.
    Lendermon EA; Dodd-o JM; Coon TA; Miller HL; Ganguly S; Popescu I; O'Donnell CP; Cardenes N; Levine M; Rojas M; Weathington NM; Zhao J; Zhao Y; McDyer JF
    Am J Respir Cell Mol Biol; 2015 May; 52(5):622-33. PubMed ID: 25286244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel model for dissecting roles of IL-17 in lung transplantation.
    Chen R; Liang F; Chen Q; Xu J; Ding Y
    J Thorac Dis; 2018 Jun; 10(6):3298-3307. PubMed ID: 30069326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pluripotent allospecific CD8+ effector T cells traffic to lung in murine obliterative airway disease.
    West EE; Lavoie TL; Orens JB; Chen ES; Ye SQ; Finkelman FD; Garcia JG; McDyer JF
    Am J Respir Cell Mol Biol; 2006 Jan; 34(1):108-18. PubMed ID: 16195540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of airway allograft tolerance by polyinosinic:polycytidylic acid requires type I interferon responsiveness for mouse airway obliteration.
    Miller HL; Shah PD; Orens JB; McDyer JF
    J Heart Lung Transplant; 2013 Sep; 32(9):914-24. PubMed ID: 23953819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-17A Blockade Attenuates Obliterative Bronchiolitis and IFN-γ Cellular Immune Response in Lung Allografts.
    Gupta PK; Wagner SR; Wu Q; Shilling RA
    Am J Respir Cell Mol Biol; 2017 Jun; 56(6):708-715. PubMed ID: 28118023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double deficiency for RORγt and T-bet drives Th2-mediated allograft rejection in mice.
    Sabet-Baktach M; Eggenhofer E; Rovira J; Renner P; Lantow M; Farkas SA; Malaisé M; Edtinger K; Shaotang Z; Koehl GE; Dahlke MH; Schlitt HJ; Geissler EK; Kroemer A
    J Immunol; 2013 Oct; 191(8):4440-6. PubMed ID: 24058178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of recipient derived interleukin-17A in a murine orthotopic lung transplant model of restrictive chronic lung allograft dysfunction.
    Yamada Y; Vandermeulen E; Heigl T; Somers J; Vaneylen A; Verleden SE; Bellon H; De Vleeschauwer S; Verbeken EK; Van Raemdonck DE; Vos R; Verleden GM; Jungraithmayr W; Vanaudenaerde BM
    Transpl Immunol; 2016 Nov; 39():10-17. PubMed ID: 27737799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-17A Is Critical for CD8+ T Effector Response in Airway Epithelial Injury After Transplantation.
    Zhang R; Fang H; Chen R; Ochando JC; Ding Y; Xu J
    Transplantation; 2018 Dec; 102(12):e483-e493. PubMed ID: 30211827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD154 deficiency uncouples allograft CD8+ T-cell effector function from proliferation and inhibits murine airway obliteration.
    Shah PD; West EE; Whitlock AB; Orens JB; McDyer JF
    Am J Transplant; 2009 Dec; 9(12):2697-706. PubMed ID: 20021479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune cells in a mouse airway model of obliterative bronchiolitis.
    Neuringer IP; Mannon RB; Coffman TM; Parsons M; Burns K; Yankaskas JR; Aris RM
    Am J Respir Cell Mol Biol; 1998 Sep; 19(3):379-86. PubMed ID: 9730865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of azithromycin and tanomastat on experimental bronchiolitis obliterans.
    Krenn K; Gmeiner M; Paulus P; Sela N; Torres L; Zins K; Dekan G; Aharinejad S
    J Thorac Cardiovasc Surg; 2015 Apr; 149(4):1194-202. PubMed ID: 25595376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of chronic lung allograft pathology in a mouse minor-mismatched orthotopic lung transplant model.
    Martinu T; Oishi H; Juvet SC; Cypel M; Liu M; Berry GJ; Hwang DM; Keshavjee S
    Am J Transplant; 2019 Jan; 19(1):247-258. PubMed ID: 30378739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement activation is not required for obliterative airway disease induced by antibodies to major histocompatibility complex class I: Implications for chronic lung rejection.
    Takenaka M; Subramanian V; Tiriveedhi V; Phelan D; Hachem R; Trulock E; Gelman AE; Patterson GA; Hoshinaga K; Mohanakumar T
    J Heart Lung Transplant; 2012 Nov; 31(11):1214-22. PubMed ID: 22980951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased myeloid cell hypoxia-inducible factor-1 delays obliterative airway disease in the mouse.
    Ropponen JO; Keränen MA; Raissadati A; Nykänen AI; Krebs R; Lemström KB; Tikkanen JM
    J Heart Lung Transplant; 2016 May; 35(5):671-8. PubMed ID: 26856676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronan contributes to bronchiolitis obliterans syndrome and stimulates lung allograft rejection through activation of innate immunity.
    Todd JL; Wang X; Sugimoto S; Kennedy VE; Zhang HL; Pavlisko EN; Kelly FL; Huang H; Kreisel D; Palmer SM; Gelman AE
    Am J Respir Crit Care Med; 2014 Mar; 189(5):556-66. PubMed ID: 24471427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell and major histocompatibility complex requirements for obliterative airway disease in heterotopically transplanted murine tracheas.
    Kelly KE; Hertz MI; Mueller DL
    Transplantation; 1998 Sep; 66(6):764-71. PubMed ID: 9771840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8+ Th17 mediate costimulation blockade-resistant allograft rejection in T-bet-deficient mice.
    Burrell BE; Csencsits K; Lu G; Grabauskiene S; Bishop DK
    J Immunol; 2008 Sep; 181(6):3906-14. PubMed ID: 18768845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rejection of tracheal allograft by intrapulmonary lymphoid neogenesis in the absence of secondary lymphoid organs.
    Wagnetz D; Sato M; Hirayama S; Matsuda Y; Juvet SC; Yeung JC; Guan Z; Zhang L; Liu M; Waddell TK; Keshavjee S
    Transplantation; 2012 Jun; 93(12):1212-20. PubMed ID: 23318304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pirfenidone inhibits obliterative airway disease in a murine heterotopic tracheal transplant model.
    McKane BW; Fernandez F; Narayanan K; Marshbank S; Margolin SB; Jendrisak M; Mohanakumar T
    Transplantation; 2004 Mar; 77(5):664-9. PubMed ID: 15021826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.